Biotia, Pioneering Pathogen Detection Company, Raises An Oversubscribed $8M Series A
Amount Raised
$8 Million
Round Type
Series A
New YorkBiotechnologyHealth CareArtificial IntelligenceHealth DiagnosticsDescription
NEW YORK, NY / August 23, 2022 / Biotia, a company fighting infectious diseases powered by genomics and artificial intelligence (AI), has raised an oversubscribed $8 million Series A round led by OCA Ventures. OCA, a veteran early stage venture firm operating from Chicago and Palo Alto was joined by other key investors including Continuum Health Ventures, Phoenix Venture Partners, SeedtoB Capital, SK Square Americas, Digital-Dx Ventures, and others. Prior Seed round investors include Falcon II Ventures, Tau Ventures, Hyperplane Venture Capital, Leawood Venture Capital, SpringTide Ventures, and others.
Quick answer
Biotia raised $8 Million in a Series A round, dated August 23, 2022. Biotia is based in New York, United States.
- How much did Biotia raise?
- Biotia raised $8 Million in a Series A round on August 23, 2022.
- What does Biotia do?
- Biotia is a health tech company located in New York, NY, that leverages sequencing-based technology and proprietary AI-powered software to rapidly and accurately identify microorganisms and antimicrobial resistance.
- Where is Biotia based and how big is it?
- Biotia is based in New York, United States. Fundz records about 28 employees.
- Who are the decision-makers at Biotia?
- Fundz holds 1 contact at Biotia, including the CEO and Co-founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Health Diagnostics and Biotechnology around the same time
Companies in the same sectors as Biotia that raised within 45 days of this round, from Fundz verified event records.
- Optellum raised $14M (Series A) on September 27, 2022.
- Secure AI Labs raised $7.9M on July 11, 2022.
- bioAffinity Technologies raised $7.7M (Post-IPO Equity) on September 28, 2022.
- DocSpera raised $10M (Funding Round) on September 27, 2022.
- Leuko raised $5M (Series A) on September 23, 2022.
- Incepto raised $27M (Funding Round) on September 19, 2022.
Who to call at Biotia, and when
A new round usually means Biotia is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Biotia raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biotia, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biotia. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biotia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBiotia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.